Stockscreener 앱 받기
4.00
5.88%
-0.25
시장 영업 전:
4.17
0.17
+4.25%
전일 마감가:
$4.25
열려 있는:
$4.26
하루 거래량:
1.64M
Relative Volume:
2.29
시가총액:
$507.43M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
112.04
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
-6.54%
1개월 성능:
-6.76%
6개월 성능:
-24.24%
1년 성능:
+43.88%
1일 변동 폭
$3.94
$4.30
1주일 범위
$3.94
$4.39
52주 변동 폭
$2.6101
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.00 | 539.15M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Organogenesis Applauds CMS’s Significant Step In Payment Reform - The Manila Times
Organogenesis Holdings Inc. Commends CMS on Payment Reform for Skin Substitutes and CTPs Under CY 2026 Fee Schedule - Quiver Quantitative
Organogenesis (Nasdaq: ORGO) applauds CMS 2026: per‑cm payments, FDA classifications finalized - Stock Titan
Is Organogenesis Holdings Inc. stock positioned for digital transformation2025 Trade Ideas & Verified Swing Trading Watchlist - newser.com
Will Organogenesis Holdings Inc. stock maintain momentum in 2025Trade Risk Summary & Weekly High Potential Stock Alerts - newser.com
Why Organogenesis Holdings Inc. stock could be next big winnerTrade Risk Report & Safe Entry Point Identification - newser.com
Asia Pacific Wound Care Biologics Market Growth in Future Scope - openPR.com
Should I hold or sell Organogenesis Holdings Inc. stock in 2025July 2025 Setups & High Accuracy Investment Signals - newser.com
Will Organogenesis Holdings Inc. outperform the marketJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Real time pattern detection on Organogenesis Holdings Inc. stockJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Detecting price anomalies in Organogenesis Holdings Inc. with AIJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
Is Organogenesis Holdings Inc. stock oversold or undervalued2025 Market Sentiment & Short-Term High Return Ideas - newser.com
Why pension funds invest in Organogenesis Holdings Inc. (2PQ) stock2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
Using Python tools to backtest Organogenesis Holdings Inc. strategiesJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
What indicators show strength in Organogenesis Holdings Inc.Quarterly Profit Report & Daily Entry Point Trade Alerts - newser.com
Is Organogenesis Holdings Inc. (2PQ) stock at risk of policy regulationWeekly Volume Report & Weekly Market Pulse Updates - newser.com
Has Organogenesis Holdings Inc. formed a bullish divergenceJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Why Organogenesis Holdings Inc. (2PQ) stock stays on top picksWeekly Profit Analysis & Reliable Entry Point Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organogenesis Holdings Inc. (ORGO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Why Organogenesis Holdings Inc. stock is trending among retail tradersBond Market & Long-Term Growth Plans - newser.com
Can Organogenesis Holdings Inc. rally from current levelsWeekly Trend Summary & Low Risk Entry Point Guides - newser.com
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Organogenesis (NASDAQ: ORGO) awards CTO inducement equity at $4.17, 4-year vesting - Stock Titan
Organogenesis Holdings Inc. (ORGO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Top chart patterns to watch in Organogenesis Holdings Inc.July 2025 Update & High Yield Stock Recommendations - newser.com
Published on: 2025-10-31 05:50:02 - newser.com
What to expect from Organogenesis Holdings Inc. in the next 30 daysWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-10-31 03:32:15 - newser.com
What high frequency data says about Organogenesis Holdings Inc.July 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Organogenesis Holdings Inc. (ORGO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Organogenesis (ORGO) Projected to Post Earnings on Thursday - MarketBeat
Key resistance and support levels for Organogenesis Holdings Inc.July 2025 Action & Stepwise Trade Signal Implementation - newser.com
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.35%
0.90%
자본화:
|
볼륨(24시간):